Edith Gwenore

Fierce Pharma Layoff Tracker 2024. About 67% of life science employees laid off during the first half of 2024 were at companies with more than $1 billion in annual sales, according to bio. Specifically, more than 130 employees.

The precision oncology biotech is laying off 30% of staff as it prioritizes pushing its lead solid tumor candidate toward a phase 2 trial in the coming. Fierce pharma delivers breaking news and analysis about drug companies, the fda and the broader pharma industry, including manufacturing, marketing and finance.